Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027985
Filing Date
2013-05-10
Accepted
2013-05-10 16:36:32
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v343215_10q.htm 10-Q 290946
2 EXHIBIT 31.1 v343215_ex31-1.htm EX-31.1 10946
3 EXHIBIT 31.2 v343215_ex31-2.htm EX-31.2 10268
4 EXHIBIT 32.1 v343215_ex32-1.htm EX-32.1 5015
5 EXHIBIT 32.2 v343215_ex32-2.htm EX-32.2 4672
  Complete submission text file 0001144204-13-027985.txt   2784762

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20130331.xml EX-101.INS 305772
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20130331.xsd EX-101.SCH 28845
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20130331_cal.xml EX-101.CAL 26063
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20130331_def.xml EX-101.DEF 154674
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20130331_lab.xml EX-101.LAB 260655
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20130331_pre.xml EX-101.PRE 192619
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 13834028
SIC: 2836 Biological Products, (No Diagnostic Substances)